Top news of the week: 21.04.2020.
Biotechnology, Malaria, Antibody, Medicine, Therapy, Vaccination
Healthcare
Scaling Up Biotech Drugs and Vaccines Against COVID19 Won't Be Easy #BioTech via https://t.co/2sI0UxJbpn https://t.co/NXDF2C1kSl
OpenScaling Up Biotech Drugs and Vaccines Against COVID19
During the Ebola crisis in 2014, I was asked to help coordinate efforts to quickly scale up manufacturing of the then-experimental ZMapp antibody cocktail. By that point, I had 30 years of ...
RT @adamfeuerstein: I missed this story from earlier in the week. $AYTU and other fly-by-night companies in deep s—t for re-selling crappy antibody tests from China. Great work by Gretchen Morgenson https://t.co/D8BDsVFFEP
OpenUnapproved Chinese coronavirus antibody tests being used in at least 2 states
Some Chinese-made COVID-19 antibody tests being used in the U.S. were not approved by China's FDA. China has now barred their export.
RT @rebeccaballhaus: “The stories on testing are all over the place, and we're actually in good shape,” Trump says in today’s briefing.
Our piece on the state of testing in the U.S., in today’s WSJ: https://t.co/wwrqoLGuDh
OpenCoronavirus Testing Hampered by Disarray, Shortages, Backlogs
State officials and labs say competition for supplies and questionable results are prolonging the national crisis. The White House put the onus on states to figure out a strategy, while ...
Biopharma Update on the Novel Coronavirus: April 17 https://t.co/gmXt1cIgli https://t.co/nchzXvkfJA
OpenBiopharma Update on the Novel Coronavirus: April 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 17, 2020.
Ori Biotech and Achilles Therapeutics Partnering to Assess Novel CGT Manufacturing https://t.co/t2ACfzqQqZ https://t.co/gHyQ0Gpzkq
OpenOri Biotech and Achilles Therapeutics Partnering to Assess Novel CGT Manufacturing
"It is always great to work with the forward-thinking leaders in cell and gene therapy, like Achilles, who are focused on innovating across the board, not just clinically and scientifically ...
Biopharma Update on the Novel Coronavirus: April 16 https://t.co/8yimRaLsBC https://t.co/f0Zll0X0qC
OpenBiopharma Update on the Novel Coronavirus: April 16
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
Chemotargets opens an investment round to enter a new phase of growth #BioTech #ux via https://t.co/2sI0UxJbpn https://t.co/KWInJCXFEm
OpenChemotargets opens an investment round to enter a new phase of growth
The IMIM's spin-off founded in 2006 by Dr. Jordi Mestres Chemotargets, a global leader in predictive analytics solutions for the pharma and biotech sector, begins a phase of …
RT @StemCellMarket: #Biotech Investing: A Complete List of Stem Cell Stocks - https://t.co/uFM9JSKNUL
Whether you’re new to biotech stocks or you’ve been around the block, with the recent stock market drops caused by COVID-19, now could be a good time to place your bets.
OpenBiotech Investing: A Complete List of Stem Cell Stocks
If you like biotech investing, now is an unique time because of market drops caused by covid-19. View a complete list of stem cell stocks.